Mizuho Securities analyst, Ann Hynes, reiterated a Buy rating and $108.00 price target on Quest Diagnostics (NYSE: DGX) ahead of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE